ABCL: Utang jangka cendhak perusahaan AbCellera Biologics Inc
AbCellera Biologics (ABCL) production capacities rely on state-of-the-art AI clusters and laboratories with minimal depreciation. Business profitability is based on partner payments for platform access and future sales royalties. The stock's price history, where the indicator stands at 0.00, confirms the company's significant pricing power due to its unique express antibody discovery method and the inelastic demand for innovative medicines.
Rincian metrik lan analitis perusahaan AbCellera (ABCL)
- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- data utang lan likuiditas:
Total Utang marang Modal AbCellera Biologics|ABCL - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas AbCellera Biologics Inc.|ABCL - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku AbCellera Biologics Inc.|ABCL - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan AbCellera|Likuiditas cepet abcellera.com
- indikator pendapatan resik lan kelipatan nilai:
Analisis wiwitan perusahaan:ABCL - AbCellera Corp
AbCellera Biologics (ABCL) monetizes its IT platform through partnerships with pharma behemoths, minimizing its own R&D expenditures. The trend in short-term debt with maturities of up to one year reflects the current pressure on the business's liquidity. This metric captures the market consensus on obligations due for repayment within twelve months. Analyzing the debt amortization trajectory allows for the timely detection of cash gap risks. This confirms the financial stability of the company's diversified model.
Analisis pesaing
ARGX - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan BNTX (BioNTech Inc.)|Abivax (ABVX) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan ADMA Corp|PTGX (Protagonist Therapeutics) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan immunovant.com|Kewajiban jangka cendhak perusahaan KNSA (Kiniksa)|GRFS (Grifols SA) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan ADPT (Adaptive Biotechnologies Corp)|Gunggunge utang jangka cendhak Celldex Corp (CLDX)|AUPH - Utang jangka cendhak perusahaan|biocryst.com (BCRX) - Kewajiban jangka cendhak perusahaan|Vera Therapeutics (VERA) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Dianthus Therapeutics Inc|Kewajiban jangka cendhak perusahaan PHVS|Utang jangka cendhak perusahaan Tourmaline|Utang jangka cendhak perusahaan Precigen, Inc. (PGEN)|pharming.com - Tanggungan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Utang jangka cendhak|Zenas Biopharma, Inc. - Utang jangka cendhak perusahaan|IMNM - Utang jangka cendhak perusahaan|GOSS: Utang jangka cendhak perusahaan|KALV (kalvista.com) - Utang jangka cendhak perusahaan|SEPN (Septerna) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Pieris Pharma (PVLA)|Utang jangka cendhak perusahaan SVRA|RIGL - Utang jangka cendhak|Utang jangka cendhak perusahaan AnaptysBio, Inc. ANAB|astriatx.com - Utang jangka cendhak perusahaan|ENGN - Utang jangka cendhak perusahaan|RAPT: Utang jangka cendhak perusahaan|JBIO: Utang jangka cendhak perusahaan|Utang jangka cendhak Aclaris Therapeutics, Inc (ACRS)|Utang jangka cendhak perusahaan Kyverna Therapeutics|TLSA: Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan CABA|Utang jangka cendhak perusahaan Ventyx Biosciences Inc. (VTYX)|Theratechnologies Inc - Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan AVTX|Eledon Pharmaceuticals - Utang jangka cendhak perusahaan|AGEN: Utang jangka cendhak perusahaan|CLYM: Utang jangka cendhak perusahaan|ZURA - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan aTyr|Utang jangka cendhak Adagene Corp ADAG|Utang jangka cendhak perusahaan ImageneBio Inc (IMA)|Utang jangka cendhak perusahaan STTK (shattucklabs.com)|Utang jangka cendhak perusahaan Equillium EQ|Connect Biopharma Holdings (CNTB) - Utang jangka cendhak|Immunic Inc - Utang jangka cendhak perusahaan|Tanggungan jangka cendhak Atara Biotherapeutics (ATRA)|IFRX: Utang jangka cendhak perusahaan|XFOR - Gunggunge utang jangka cendhak|ACET (Adicet Bio Inc.) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Celularity Corp (CELU)|Utang jangka cendhak perusahaan INmune Bio Corp (INMB)|Gunggunge utang jangka cendhak Barinthus Biotherapeutics Corp|Utang jangka cendhak perusahaan KZR (Kezar Life Sciences)|Utang jangka cendhak perusahaan sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Utang jangka cendhak perusahaan|ENLV: Utang jangka cendhak perusahaan|QTTB: Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan GeoVax Corp|Utang jangka cendhak perusahaan Edesa Biotech, Inc.|Utang jangka cendhak perusahaan IBIO|Utang jangka cendhak perusahaan Carisma Therapeutics (CARM)|XTLB: Kewajiban jangka cendhak|Utang jangka cendhak perusahaan BOLT (Bolt Biotherapeutics, Inc.)|Silihan lan utang jangka cendhak perusahaan HCWB|Aptevo - Utang jangka cendhak perusahaan|AIM - Utang jangka cendhak perusahaan|aditxt.com (ADTX) - Utang jangka cendhak perusahaan|GRI Bio Inc - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan XORTX|Kewajiban jangka cendhak perusahaan Vyome Therapeutics (HIND)|Utang jangka cendhak perusahaan REVB|Utang jangka cendhak perusahaan indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan CALI|Affimed Therapeutics - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak Allakos Inc. ALLK|hookipapharma.com (HOOK) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan IGM Biosciences|Utang jangka cendhak perusahaan iTeos Therapeutics, Inc.|Kewajiban jangka cendhak perusahaan Ocean Biomedical Inc (OCEA)|Kewajiban jangka cendhak perusahaan TCBP (TC BioPharm (Holdings) PLC)|Utang jangka cendhak perusahaan Third Harmonic Bio Inc (THRD)